Hyperion Australian Growth Companies PIE Fund
Managed by Hyperion Hyperion Australian Growth Companies PIE Fund is a australasian equities managed fund operated by Hyperion; PIE-structured; FMA risk indicator 6/7. Headline terms: annual fund charge 0.98% · minimum investment NZ$20,000 · distributions no distributions (accumulating). Compared with 57 other same-category funds on this site, the 0.98% annual fund charge sits in line with the same-category median of 1.02%.
PIE tax treatment — capped at your PIR (max 28%)
This fund is a Portfolio Investment Entity (PIE) under Subpart HM of the Income Tax Act 2007. Income is taxed at your Prescribed Investor Rate (10.5% / 17.5% / 28%), not your marginal income-tax rate. The fund manager calculates and pays the tax on your behalf — when your PIR is correct, you usually don't need to declare PIE income in your annual tax return. See our PIR guide and PIE tax basics for the full picture, or use the PIR calculator to confirm your rate.
Annual fund charge
0.98%
vs peer avg 0.91%
Risk indicator
6/7
1 = lower risk · 7 = higher risk
5-year return p.a.
Less than 5 years of data
peer avg 4.91%
Fund size
NZ$54.7m
98% growth · 2% income
The investment objective is to achieve long-term returns above the S&P/ASX 300 Accumulation Index in NZ dollars, and minimise the risk of permanent capital loss.
How Hyperion Australian Growth Companies PIE Fund differs
Factual contrasts drawn from the PDS, SIPO and latest portfolio holdings — no opinion.
- Benchmark
- S&P/ASX 300 Accumulation Index (NZD)
- Top 3 holdings
- Bhp Group Limited Ordinary Fully Paid (10.1%) · Fisher & Paykel Healthcare (9.3%) · Sigma Pharmaceuticals Limited Ordinary Fully Paid (8.9%)
Key facts
Fund start date
9 July 2024
Min. investment
NZ$20,000
Subsequent: NZ$1,000
Distributions
No distributions (accumulating)
Buy / sell spread
30 bps (0.30%) / 30 bps (0.30%)
Transaction cost on subscription / redemption
Tax structure
PIE
Capped at your PIR (max 28%)
Investment policy
From the Statement of Investment Policy and Objectives (SIPO).
Strategic asset allocation ranges
| Asset class | Target | Min | Max |
|---|---|---|---|
| Australian equities | 95% | 70% | 100% |
| Cash and cash equivalents | 5% | 0% | 20% |
| Global equities | 0% | 0% | 10% |
Responsible-investment approach
Hyperion applies ESG considerations (environmental, social including labour standards, and ethical incorporating corporate governance) when selecting, retaining or realising investments, assessed on a case-by-case basis without fixed methodology or weightings. ESG analysis produces an ESG Score that feeds into a Business Quality Score, which directly influences portfolio weightings. Hyperion may divest investments no longer suitable due to ESG considerations.
Exclusions
- Short selling of equity securities is not permitted
- Fund is not permitted to own more than 15% of any one company (measured by share capital)
Reading between the lines
Plain-English summary of the scheme's disclosed conflicts and performance-fee mechanics, drawn from the OMI and PDS. Factual restatement — no opinion.
- FundRock NZ acknowledges that because it and registry manager Apex NZ share the same ultimate parent (Apex Group), FundRock may agree registry contract terms more favourable to Apex NZ than to investors.
- FundRock delegates registry services to related party Apex Investment Administration (NZ) Limited under an Administration Agreement, meaning fund costs flow to a company under common ownership with the manager.
- The Hyperion Global Growth Companies PIE Fund charges a performance fee of 20% of outperformance above benchmark, calculated on NAV each six months, but only after prior underperformance is recovered and the fund return is at or above 0.00%.
Generated 2026-05-28 from Hyperion Investment Funds OMI (dated 2026-03-30). The verbatim disclosures appear in full below — this summary is a navigation aid, not a substitute.
Scheme disclosures
From the Other Material Information (OMI) document. Scheme-level — applies to every fund in this scheme.
Trustee / Supervisor
Public Trust
Auditor
PricewaterhouseCoopers
Custodian
BNP Paribas Fund Services Australasia Pty Limited
Conflicts disclosed
2
In OMI
Conflicts of interest disclosed in OMI
- FundRock NZ Limited and the Scheme's registry manager Apex Investment Administration (NZ) Limited are ultimately owned by Apex Group Limited, which may influence FundRock to agree commercial terms with Apex NZ that are more favourable to Apex NZ than would otherwise be the case, benefiting Apex NZ at the expense of investors.
- Parties related to the Funds, including the staff of Hyperion and their families, and the staff of FundRock and their families, may from time to time invest in the Funds.
How this fund compares to peers
Mechanical comparison vs the 58 other australasian equities funds in our cohort. Source: FMA Disclose register via Sorted Smart Investor. Past performance is not a reliable indicator of future returns.
Annual fund charge
0.98%
Category median: 1.01%
Cheaper than 53% of peers
Fund size
NZ$54.7m
Category median: NZ$74.1m
44th percentile by AUM
Illustrative 5y fee impact on a sample balance of $10,000
$480
Compounded charge over 5 years (excl. returns)
$14 less than peer median
Read the full fee-vs-peers breakdown →
Mechanical scores only — no opinion or recommendation. Different funds suit different investor goals. ManagedFundsNZ is not a Financial Advice Provider. Read the current PDS and consider speaking to a licensed financial adviser.
Top 10 holdings
As at the latest published quarterly fund update (via Sorted Smart Investor).
| Holding | % of fund |
|---|---|
 Bhp Group Limited Ordinary Fully Paid | 10.05% |
 Fisher & Paykel Healthcare | 9.30% |
| SP Sigma Pharmaceuticals Limited Ordinary Fully Paid | 8.89% |
| BC Block Inc. Cdi 1 1 Foreign Exempt Nyse | 8.73% |
 Macquarie Group Ltd | 7.59% |
| CO Cochlear Limited | 5.78% |
| HO Hub24 Limited Ordinary Fully Paid | 5.45% |
 Goodman Group | 4.00% |
| TO Technology One Limited | 3.95% |
| LI Life360 Inc | 3.57% |
Documents
Every dated PDS, quarterly fund update and full-portfolio holdings file. Linked from the FMA Disclose register via Sorted Smart Investor.
- HYPERION AUSTRALIAN GROWTH COMPANIES PIE FUND (FND49636) Full portfolio holdings 31 March 2026.xlsx Download the full portfolio holdings. XLSX, 1.18 KB
- 20260401 Hyperion Investment Funds PDS.pdf How this investment works, including about the provider, risks, costs and potential returns PDF, 380.20 KB
- 20260331 Hyperion Australian Growth Companies PIE QFU.pdf The quarterly update published by the provider PDF, 464.67 KB
- 20260401 Hyperion Investment Funds OMI.pdf Other Material Information document PDF, 446.18 KB
- 20260401 Hyperion Investment Funds SIPO.pdf Statement of investment policy and objectives PDF, 333.92 KB
About this category
Funds investing primarily in shares listed on the NZX (New Zealand) or ASX (Australia), or both as Trans-Tasman portfolios. Includes active stock-pickers and passive index trackers.
About Hyperion
Australian active manager focused on high-quality global growth companies. NZ PIE wrapper issued by FundRock NZ.
Parent: FundRock NZ (issuer)
See all funds from Hyperion →Common questions
Questions people ask about Hyperion Australian Growth Companies PIE Fund
Drawn from Google's "People also ask" panel and answered with reference to the fund's filed PDS, Fund Update and FMA Disclose data. Not personal financial advice — for guidance specific to your situation, consult an authorised financial adviser.
What does Hyperion invest in?
Hyperion Australian Growth Companies PIE Fund invests approximately 98.31% in growth assets and 1.69% in income assets, with a portfolio that includes major holdings such as BHP Group Limited (10.05%), Fisher & Paykel Healthcare (9.3%), and Sigma Pharmaceuticals Limited (8.89%), as at the latest QFU. The fund is categorised as Australasian Equities and carries a risk indicator of 6/7 on the FMA standardised scale.
What is a reasonable fee for a managed fund?
Annual fund charges vary by fund type and asset class. For Australasian Equities funds, the peer-cohort average annual fund charge is 0.95% p.a., while Hyperion Australian Growth Companies PIE Fund charges 0.98% p.a. You can compare current fees for funds in this category on the FMA Disclose register at https://disclose-register.companiesoffice.govt.nz/.
What is a typical management fee for a fund?
Management fees depend on the fund's asset class and investment strategy. Australasian Equities funds typically charge between 0.90% and 1.00% p.a., with Hyperion Australian Growth Companies PIE Fund charging 0.98% p.a. For a full comparison of fees across managed funds, check the FMA Disclose register.
Head-to-head
Compare Hyperion Australian Growth Companies PIE Fund with…
Side-by-side numbers — fees, returns, risk, fund size, asset mix.
Peer funds
Other Australasian Equities funds
FMA risk band
Same risk band (6/7)
See every NZ retail managed fund with the same standardised FMA risk indicator. Useful for peer-checking volatility-comparable funds outside this category.
View risk band 6 funds →Explore this with AI
Open a fresh AI chat pre-loaded with this page — ask it to summarise, explain, or compare, and it can read ManagedFundsNZ's underlying data directly.
AI & integrations
Use this fund inside the tools you already use
Every fund on ManagedFundsNZ ships in three formats so AI assistants and data tools can consume it without scraping: a canonical HTML page, a plain Markdown twin, and a structured JSON twin. Citation back to the canonical URL is required; full reuse policy at /llms-policy.txt.
- Canonical (HTML)managedfunds.nz/funds/hyperion/australian-growth-companies/This page. Browsable.
- Markdown twinmanagedfunds.nz/funds/hyperion/australian-growth-companies/markdown.mdPlain text. AI-crawler-ready.
- Structured (JSON)managedfunds.nz/funds/hyperion/australian-growth-companies/data.jsonMachine-parseable.
Frequently asked questions
Mechanical Q&A grounded in the fund's PDS, SIPO, and latest QFU on the FMA Disclose register. Verify against the source before relying on any of this.
Who manages the Hyperion Australian Growth Companies PIE Fund?
Hyperion Australian Growth Companies PIE Fund is managed by Hyperion (parent: FundRock NZ (issuer)). Australian active manager focused on high-quality global growth companies. NZ PIE wrapper issued by FundRock NZ.
What asset class is the Hyperion Australian Growth Companies PIE Fund?
It is a australasian equities managed fund. Funds investing primarily in shares listed on the NZX (New Zealand) or ASX (Australia), or both as Trans-Tasman portfolios. Includes active stock-pickers and passive index trackers.
What are the fees for the Hyperion Australian Growth Companies PIE Fund?
The annual fund charge for the Hyperion Australian Growth Companies PIE Fund is 0.98% p.a., as reported in the latest Quarterly Fund Update sourced from the FMA Disclose register. Always check the current PDS for any additional fees.
What is the risk indicator for the Hyperion Australian Growth Companies PIE Fund?
The risk indicator is 6/7 on the standardised FMA-mandated scale, where 1 is lower risk and 7 is higher risk. The risk indicator is calculated from the fund's price volatility over the past five years and is published in every Quarterly Fund Update.
Is the Hyperion Australian Growth Companies PIE Fund a PIE fund?
Yes. The Hyperion Australian Growth Companies PIE Fund is structured as a New Zealand Portfolio Investment Entity (PIE). Investor tax on the fund's income is capped at the investor's Prescribed Investor Rate (PIR), which has a maximum of 28%. Most NZ-resident retail investors with a taxable income at or below NZ$48,000 qualify for a lower PIR.
How big is the Hyperion Australian Growth Companies PIE Fund?
Fund size (assets under management) is NZ$55 million as at the latest Quarterly Fund Update. Asset mix is approximately 98% growth assets and 2% income assets.
What does the Hyperion Australian Growth Companies PIE Fund invest in?
The latest published top holdings are: Bhp Group Limited Ordinary Fully Paid (10.05%), Fisher & Paykel Healthcare (9.30%), Sigma Pharmaceuticals Limited Ordinary Fully Paid (8.89%). Holdings are disclosed in each Quarterly Fund Update; the full portfolio holdings file is also available via the FMA Disclose register.
How can I invest in the Hyperion Australian Growth Companies PIE Fund?
The Hyperion Australian Growth Companies PIE Fund is available via Hyperion directly. Always read the current Product Disclosure Statement before investing.
What does Hyperion invest in?
Hyperion Australian Growth Companies PIE Fund invests approximately 98.31% in growth assets and 1.69% in income assets, with a portfolio that includes major holdings such as BHP Group Limited (10.05%), Fisher & Paykel Healthcare (9.3%), and Sigma Pharmaceuticals Limited (8.89%), as at the latest QFU. The fund is categorised as Australasian Equities and carries a risk indicator of 6/7 on the FMA standardised scale.
What is a reasonable fee for a managed fund?
Annual fund charges vary by fund type and asset class. For Australasian Equities funds, the peer-cohort average annual fund charge is 0.95% p.a., while Hyperion Australian Growth Companies PIE Fund charges 0.98% p.a. You can compare current fees for funds in this category on the FMA Disclose register at https://disclose-register.companiesoffice.govt.nz/.
What is a typical management fee for a fund?
Management fees depend on the fund's asset class and investment strategy. Australasian Equities funds typically charge between 0.90% and 1.00% p.a., with Hyperion Australian Growth Companies PIE Fund charging 0.98% p.a. For a full comparison of fees across managed funds, check the FMA Disclose register.